Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT03386266
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of CMT1A
* Genetic confirmation of PMP22 duplication (for adults patients)
* Children aged 3-11, adolescents aged 12-17 and adults aged 18-65 years
* Signed informed patient consent
Exclusion Criteria:
* Other causes of neurological and psychiatric disorders
* Severe internistic disease
* Patient known or suspected to be alcohol / drug abuser
* Pregnancy, breast feeding period
* Permanent Vitamin C intake
* Participation an interventional clinical study up to 4 weeks prior to inclusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
65 Years
Study:
NCT03386266
Study Brief:
Protocol Section:
NCT03386266